FDA Approved: FABRAZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

The FDA approved a supplemental application for FABRAZYME (agalsidase beta) submitted by Genzyme Corporation. FABRAZYME is an enzyme replacement therapy used to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• FABRAZYME (Agalsidase beta)

Snippet

SUPPL AP for FABRAZYME (AGALSIDASE BETA)